Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial
Title:
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial
Author:
Clarke, David K Xu, Rong Matassov, Demetrius Latham, Theresa E Ota-Setlik, Ayuko Gerardi, Cheryl S Luckay, Amara Witko, Susan E Hermida, Luz Higgins, Terry Tremblay, Marc Sciotto-Brown, Susan Chen, Tracy Egan, Michael A Rusnak, Janice M Ward, Lucy A Eldridge, John H